Clinical Trial Update: Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia A [Phase 2]

View source ↗

Summary

Phase 2 study of Biostate, a plasma-derived von Willebrand factor/factor VIII concentrate, in Hemophilia A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Biostate (plasma-derived von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia A | Phase 2 | Status: COMPLETED